Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Yongji Zou"'
Autor:
Ping Ren, Yingxia Hu, Lei Peng, Luojia Yang, Kazushi Suzuki, Zhenhao Fang, Meizhu Bai, Liqun Zhou, Yanzhi Feng, Yongji Zou, Yong Xiong, Sidi Chen
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-4 (2023)
Externí odkaz:
https://doaj.org/article/15a5f16c0fbc450ab401029017a45f9f
Autor:
Lupeng Ye, Stanley Z. Lam, Luojia Yang, Kazushi Suzuki, Yongji Zou, Qianqian Lin, Yueqi Zhang, Paul Clark, Lei Peng, Sidi Chen
Publikováno v:
bioRxiv
Adoptive cell therapy has shown clinical success in patients with hematological malignancies. Immune cell engineering is critical for production, research, and development of cell therapy; however, current approaches for generation of therapeutic imm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e37518c57b9e8ef93b9851eabf1533d
https://doi.org/10.1101/2023.03.14.532651
https://doi.org/10.1101/2023.03.14.532651
Autor:
Ping Ren, Yingxia Hu, Lei Peng, Luojia Yang, Kazushi Suzuki, Zhenhao Fang, Meizhu Bai, Liqun Zhou, Yanzhi Feng, Yongji Zou, Yong Xiong, Sidi Chen
Publikováno v:
bioRxiv
The SARS-CoV-2 variant, Omicron (B.1.1.529), rapidly swept the world since its emergence. Compared with previous variants, Omicron has a high number of mutations, especially those in its spike glycoprotein that drastically dampen or abolish the effic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38d3976546d48cfdf22a55272b9724d0
https://doi.org/10.1101/2022.08.09.503414
https://doi.org/10.1101/2022.08.09.503414